Tauns

Tauns Laboratories, Inc. is a prominent Japanese biotechnology company specializing in the development and manufacture of rapid diagnostic test kits for infectious diseases. The company is widely recognized for its Capilia brand, which utilizes advanced lateral flow immunoassay technology to provide quick, point-of-care results without the need for specialized laboratory equipment. Their product portfolio covers a broad range of pathogens, including influenza, SARS-CoV-2, RSV, and various gastrointestinal viruses. Tauns focuses on enhancing clinical efficiency by enabling rapid diagnosis and immediate treatment decisions in healthcare settings. In 2022, the company was acquired by H.U. Group Holdings, Inc., integrating it into one of Japan's largest healthcare testing and diagnostic networks. Tauns continues to expand its global footprint, supplying diagnostic solutions to international markets to combat infectious disease outbreaks.